Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1182/blood-2017-01-734558 http://scihub22266oqcxt.onion/10.1182/blood-2017-01-734558 C5533200!5533200!28600340     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28600340.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Blood 2017 ; 130 (4): 460-5 Nephropedia Template TP {{tp|p=28600340|t=2017. Ethical considerations in genomic testing for hematologic disorders |pdf=|usr=}}{{28600340}} gab.com Text Ethical considerations in genomic testing for hematologic disorders JO: Blood http://www.kidney.de/pget.php?&tw=1&pmid=28600340 #FOAvip As our technological capacities improve, genomic testing is increasingly integrating into patient care. The field of clinical hematology is no exception. Genomic testing carries great promise, but several ethical issues must be considered whenever such testing is performed. This review addresses these ethical considerations, including issues surrounding informed consent and the uncertainty of the results of genomic testing; the challenge of incidental findings; and possible inequities in access to and benefit from such testing. Genomic testing is likely to transform the practice of both benign and malignant hematology, but clinicians must carefully consider these core ethical issues in order to make the most of this exciting and evolving technology. Twit Text FOAVip Ethical considerations in genomic testing for hematologic disorders ????Blood http://www.kidney.de/pget.php?&tw=1&pmid=28600340 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28600340 #FOAvip English Wikipedia <ref>{{Cite pmid|28600340}}</ref> Ethical considerations in genomic testing for hematologic disorders #MMPMID28600340 Marron JM; Joffe S Blood 2017[Jul]; 130 (4): 460-5 PMID28600340show ga As our technological capacities improve, genomic testing is increasingly integrating into patient care. The field of clinical hematology is no exception. Genomic testing carries great promise, but several ethical issues must be considered whenever such testing is performed. This review addresses these ethical considerations, including issues surrounding informed consent and the uncertainty of the results of genomic testing; the challenge of incidental findings; and possible inequities in access to and benefit from such testing. Genomic testing is likely to transform the practice of both benign and malignant hematology, but clinicians must carefully consider these core ethical issues in order to make the most of this exciting and evolving technology. äEthical considerations in genomic testing for hematologic disorders (epmc).pdf DeepDyve Pubget Overpricing